Atlas Venture Advisors, Inc. - Q4 2020 holdings

$446 Million is the total value of Atlas Venture Advisors, Inc.'s 8 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 50.0% .

 Value Shares↓ Weighting
DKNG SellDRAFTKINGS INC$339,143,000
-30.4%
7,284,008
-12.1%
76.05%
-7.2%
TBIO SellTRANSLATE BIO INC$48,960,000
-6.2%
2,656,517
-30.7%
10.98%
+25.1%
ROKU  ROKU INC$19,160,000
+75.9%
57,7070.0%4.30%
+134.4%
SNAP  SNAP INCcl a$12,295,000
+91.7%
245,5590.0%2.76%
+155.5%
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$10,998,000
-55.8%
612,696
-53.1%
2.47%
-41.1%
LRMR  LARIMAR THERAPEUTICS INC$6,256,000
+41.2%
292,1840.0%1.40%
+88.1%
FSTX NewF-STAR THERAPEUTICS INC$5,675,000574,996
+100.0%
1.27%
VRDN NewMIRAGEN THERAPEUTICS INC$3,446,000209,505
+100.0%
0.77%
MGEN ExitMIRAGEN THERAPEUTICS INC$0-3,142,580
-100.0%
-0.41%
DDOG ExitDATADOG INC$0-56,616
-100.0%
-0.97%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-01
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SNAP INC20Q3 20236.1%
ROKU INC16Q3 202311.7%
LARIMAR THERAPEUTICS INC14Q3 20231.4%
TRANSLATE BIO INC11Q2 202152.9%
INTEGRAL AD SCIENCE HLDNG CO10Q3 202371.2%
BICYCLE THERAPEUTICS PLC10Q3 202125.2%
VIRIDIAN THERAPEUTICS INC10Q1 20232.1%
F-STAR THERAPEUTICS INC9Q4 20221.3%
DRAFTKINGS INC8Q1 202282.5%
MIRAGEN THERAPEUTICS INC8Q3 20205.0%

View Atlas Venture Advisors, Inc.'s complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-02
13F-HR2023-11-13
13F-HR2023-08-08
13F-HR2023-05-08
13F-HR2023-01-31
13F-HR2022-11-10
13F-HR2022-08-11
13F-HR2022-05-12
13F-HR2022-01-27
13F-HR2021-11-04

View Atlas Venture Advisors, Inc.'s complete filings history.

Compare quarters

Export Atlas Venture Advisors, Inc.'s holdings